All NICE products on inflammatory bowel disease. Includes any guidance, advice, NICE Pathways and quality standards.
This quality standard covers diagnosing and managing inflammatory bowel disease (Crohn’s disease and ulcerative colitis) in adults, young people and children. It describes high-quality care in priority areas for improvement.
Advice on PredictSure-IBD for inflammatory bowel disease prognosis to aid local decision making
Evidence-based recommendations on leukapheresis for inflammatory bowel disease (IBD) (ulcerative colitis and Crohn's disease)
This guideline covers using colonoscopy to check for signs of bowel cancer in people aged 18 and over with ulcerative colitis or Crohn’s disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to prevent cancer and prolong life by offering advice on identifying early bowel cancer in adults most at risk.
Everything NICE has said on managing Crohn's disease in children, young people and adults in an interactive flowchart
Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart
Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease
Everything NICE has said on diagnosing and managing irritable bowel syndrome in adults in primary care in an interactive flowchart
Advice on the use of RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (IBD) to aid local decision-making
Evidence-based recommendations on faecal calprotectin diagnostic tests for inflammatory diseases of the bowel
history of progression to colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas? Any explanatory...
In development [GID-DG10029] Expected publication date: 26 August 2020
Evidence-based recommendations on therapeutic monitoring of TNF-alpha inhibitors in Crohn’s disease
Evidence-based recommendations on bioprosthetic plug insertion for anal fistula in adults